Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Masitinib vs dacarbazine in unresectable or metastatic melanoma with c-kit JM mutations
CTR20160315Phase 3Active
- Sponsor
- AB Science
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of masitinib in melanoma, sponsored by AB Science. Started Aug 2016; status: active.
02
Drugs
masitinib
03
Conditions
melanoma
Beyond the preview
Go deeper on CTR20160315.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20160315.